Clinical Trial

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-01; most recent amendment 2026-03-25.
Trial Details
NCT Number NCT06915246
Lead Sponsor VIVUS LLC
Conditions Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Enrollment 49 participants
Start Date 2025-03-12
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-27